| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 753456 | 2-4-[5-(3,5-dimethoxyphenyl)-1H-1-imidazolyl]phenyl-5,6,7-trimethoxy-1,3-benzothiazole | 0.0237269271456697 | 0.27021612 |
| NSC 744469 | 3-cyano-3,3-diphenylpropyl 4-(3-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypropyl)-1-piperazinecarbodithioate | 0.0291420747327558 | 0.61913905 |
| NSC 130279 | 7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 3,4-dihydro-3-.beta.-D-ribofuranosyl- (9CI) | 0.029142074732756 | 0.18679342 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.029142074732756 | 0.34299717 |
| NSC 134723 | K 31 | 0.029142074732756 | 0.11814599 |
| NSC 135962 | Aracytidine 5'-palmitate | 0.029142074732756 | 0.046226969 |
| NSC 175493 | Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- | 0.029142074732756 | 0.24948416 |
| NSC 176328 | Ellipticine, 6-(3-aminopropyl)-, dihydrochloride | 0.029142074732756 | 0.18361547 |
| NSC 21683 | Null | 0.029142074732756 | 0.12649194 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.029142074732756 | 0.040811302 |